
NightHawk Biosciences, Inc.
NHWK
NHWK: NightHawk Biosciences Inc is a commercial-stage company with a fully integrated ecosystem to accelerate the discovery and development of novel therapies that arm the immune system. By leveraging its proprietary platforms, the company is advancing its first-in-class product portfolio with a focus on cancer and inflammatory and infectious diseases. Its current pipeline has categories: Oncology, immunology and molecular biology.
moreShow NHWK Financials
Recent trades of NHWK by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by NHWK's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on NHWK's company Twitter account
Number of mentions of NHWK in WallStreetBets Daily Discussion
Recent insights relating to NHWK
Recent picks made for NHWK stock on CNBC
ETFs with the largest estimated holdings in NHWK
Flights by private jets registered to NHWK